Incidence of type 2 diabetes in Aboriginal Australians: an 11-year prospective cohort study

Zhiqiang Wang; Hoy, Wendy E.; Si, Damin
January 2010
BMC Public Health;2010, Vol. 10 Issue 1, p487
Academic Journal
Background: Diabetes is an important contributor to the health inequity between Aboriginal and non-Aboriginal Australians. This study aims to estimate incidence rates of diabetes and to assess its associations with impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) among Aboriginal participants in a remote community. Methods: Six hundred and eighty six (686) Aboriginal Australians aged 20 to 74 years free from diabetes at baseline were followed for a median of 11 years. During the follow-up period, new diabetes cases were identified through hospital records. Cox proportional hazards models were used to assess relationships of the incidence rates of diabetes with IFG, IGT and body mass index (BMI). Results: One hundred and twenty four (124) new diabetes cases were diagnosed during the follow up period. Incidence rates increased with increasing age, from 2.2 per 1000 person-years for those younger than 25 years to 39.9 per 1000 person-years for those 45-54 years. By age of 60 years, cumulative incidence rates were 49% for Aboriginal men and 70% for Aboriginal women. The rate ratio for developing diabetes in the presence of either IFG or IGT at baseline was 2.2 (95% CI: 1.5, 3.3), adjusting for age, sex and BMI. Rate ratios for developing diabetes were 2.2 (95% CI: 1.4, 3.5) for people who were overweight and 4.7 (95% CI: 3.0, 7.4) for people who were obese at baseline, with adjustment of age, sex and the presence of IFG/IGT. Conclusions: Diabetes incidence rates are high in Aboriginal people. The lifetime risk of developing diabetes among Aboriginal men is one in two, and among Aboriginal women is two in three. Baseline IFG, IGT and obesity are important predictors of diabetes.


Related Articles

  • The burden of treatment failure in type 2 diabetes. Brown, Jonathan B.; Nichols, Gregory A.; Perry, Andrew // Diabetes Care;Jul2004, Vol. 27 Issue 7, p1535 

    Objective: In type 2 diabetes, therapies to maintain blood glucose control usually fail after several years. We estimated the glycemic burden that accumulates from treatment failure and describe the time course and predictors of failure.Research Design and Methods: A...

  • Canagliflozin: A Novel SGLT2 Inhibitor for Type 2 Diabetes Mellitus. Kaushal, Shaveta; Singh, Harmanjit; Thangaraju, Pugazhenthan; Singh, Jasbir // North American Journal of Medical Sciences;Mar2014, Vol. 6 Issue 3, p107 

    Diabetes Mellitus continues to be a major non- communicable disease with global burden of 366 million at present and projected to increase to 439 to 552 million by 2030, India being the hub of diabetes. Sodium glucose transporter 2 (SGLT2) inhibitors presents a new class of anti-diabetic drugs...

  • The antidiabetic gutsy role of metformin uncovered? Burcelin, Rémy // Gut;May2014, Vol. 63 Issue 5, p706 

    The author comments on the research study concerning on the medical role of metformin as treatment for lowering hyperglycaemia in type 2 diabetic patients. He mentions the antidiabetic effect of metformin abrogated by an antibiotic treatment reinforcing the significant of gut microbiota. He also...

  • To lower or not to lower? Making sense of the latest research on intensive glycaemic control and cardiovascular outcomes. Sherifali, Diana; Punthakee, Zubin // Evidence Based Nursing;Jan2009, Vol. 12 Issue 1, p25 

    The article discusses the global prevalence of diabetes and reports on three research studies which investigated the cardiovascular effects of lowering glucose to near normal concentrations in patients with type two diabetes. A discussion of a large degree of confusion and debate which resulted...

  • Achieving glycemic control with insulin in type 2 diabetes. Bell, David S.; Leahy, John L.; Piziak, Veronica K. // Patient Care for the Nurse Practitioner;Oct2002, Vol. 5 Issue 10, p6 

    The article discusses the use of insulin to achieve glycemic control in type 2 diabetes. When dietary modification, an exercise program, and 2 or 3 oral antidiabetic agents can no longer control the blood glucose level in patients with type 2 diabetes, it is time to consider insulin therapy....

  • Beating the sugar blues with nature.  // Food & Drink Technology;Mar2007, Vol. 6 Issue 6, p14 

    The article provides information about the efficiency of Chromium Picolinate used in improving the condition of type 2 diabetes patients in Great Britain. It has been stated that diabetes affects the stability of the body's insulin response and several million people in the country will become...

  • Insulin-based therapies in type 2 diabetes.  // Journal of Endocrinology, Metabolism & Diabetes of South Africa;Mar2012, Vol. 17 Issue 1, pS32 

    The article presents several studies conducted on examining the insulin-based therapies in type 2 diabetes. One study reveals that patients with type 2 diabetes assigned to receive a basal, biphasic or prandial insulin regimen, the mean glycated haemoglobin levels at one year were similar in the...

  • The 2012 SEMDSA Treatment Algorithm for Type 2 Diabetes.  // Journal of Endocrinology, Metabolism & Diabetes of South Africa;Mar2012, Vol. 17 Issue 1, pS36 

    Several tables are presented discussing 2012 Society for Endocrinology, Metabolism and Diabetes of South Africa (SEMDSA) Treatment Algorithm for type 2 diabetes including one on antihyperglycaemic agents used in type 2 diabetes and antihyperglycaemic agents used in type 2 diabetes.

  • Should GPs lower HbA1c targets? Moberly, Tom // GP: General Practitioner;5/7/2010, p26 

    The article focuses on the debate that whether hemoglobin A1c (HbA1c) targets should be lowered or not in patients with type-2 diabetes. It states that action to control cardiovascular risk in diabetes (ACCORD) study published in the 2010 issue of the periodical "Diabetes Care" reveals that...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics